Breaking News Instant updates and real-time market news.

CHRS

Coherus Biosciences

$25.25

-0.53 (-2.06%)

16:12
10/06/16
10/06
16:12
10/06/16
16:12

Coherus BioSciences completes PK studies of CHS-0214

Coherus BioSciences announced results from two pharmacokinetic studies involving CHS-0214, a biosimilar candidate to etanercept, Enbrel. CHS-0214-06 was a Phase 1 pharmacokinetic bioequivalence study comparing CHS-0214 vs. European Union Enbrel. The '06 Study achieved the primary PK BE endpoint, as the 90% confidence intervals for the geometric mean ratio for the two groups was within 80% to 125% for all PK parameters. CHS-0214-07 is an additional, non-pivotal, Phase 1 bridging study. As anticipated, this study provided additional relative bioavailability data for CHS-0214. As planned, Coherus is moving forward with pre-submission meetings, now expected in the first quarter 2017, to review the complete CHS-0214 program prior to filing. The planned marketing authorizations submissions will occur directly thereafter.

  • 06

    Nov

CHRS Coherus Biosciences
$25.25

-0.53 (-2.06%)

05/10/16
COWN
05/10/16
NO CHANGE
Target $45
COWN
Outperform
Cowen sees potential for significant value creation at Coherus Biosciences
Cowen said Coherus Biosciences has multiple upcoming triggers which could result in significant value creation for shareholders. The firm noted the company has three biosimilar products in late stage development with others soon to enter the clinic. Cowen reiterated its Outperform rating and $45 price target on Coherus shares.
07/27/16
SBSH
07/27/16
INITIATION
Target $36
SBSH
Buy
Coherus Biosciences initiated with a Buy at Citi
Citi analyst Mohit Bansal started Coherus Biosciences with a Buy rating and $36 price target. Neulasta and Humira biosimilar clarity in the next 12 months should provide upside, the analyst contends.
07/27/16
07/27/16
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. TAL Education (XRS) initiated with a Buy at Brean Capital. 2. Coherus Biosciences (CHRS) initiated with a Buy at Citi. 3. Verso Corp. (VRS) initiated with a Buy at BWS Financial. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/07/16
MAXM
09/07/16
INITIATION
Target $43
MAXM
Buy
Coherus Biosciences initiated with a Buy at Maxim
Maxim analyst Jason McCarthy initiated Coherus Biosciences with a Buy and $43 price target.

TODAY'S FREE FLY STORIES

IBTX

Independent Bank

$63.00

3.1 (5.18%)

17:05
04/24/17
04/24
17:05
04/24/17
17:05
Earnings
Independent Bank reports Q1 core EPS 84c, consensus 81c »

Net interest income was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

CR

Crane

$77.91

1.37 (1.79%)

17:03
04/24/17
04/24
17:03
04/24/17
17:03
Earnings
Crane raises FY17 EPS view to $4.35-$4.55 from $4.30-$4.55, consensus $4.45 »

Max Mitchell, Crane Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 09

    May

CR

Crane

$77.91

1.37 (1.79%)

17:02
04/24/17
04/24
17:02
04/24/17
17:02
Earnings
Crane reports Q1 EPS $1.05, consensus $1.00 »

Reports Q1 revenue $673M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 09

    May

MRK

Merck

$62.14

0.25 (0.40%)

, BIIB

Biogen

$276.86

3.92 (1.44%)

17:02
04/24/17
04/24
17:02
04/24/17
17:02
Hot Stocks
FDA clears Remicade biosimilar from Samsung Bioepis »

The FDA has granted…

MRK

Merck

$62.14

0.25 (0.40%)

BIIB

Biogen

$276.86

3.92 (1.44%)

JNJ

Johnson & Johnson

$122.89

1.13 (0.93%)

SSNLF

Samsung

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 02

    May

  • 03

    May

  • 07

    May

  • 10

    May

  • 27

    May

  • 31

    May

  • 06

    Jun

  • 09

    Jun

  • 14

    Jun

AMP

Ameriprise

$131.86

3.42 (2.66%)

17:01
04/24/17
04/24
17:01
04/24/17
17:01
Hot Stocks
Breaking Hot Stocks news story on Ameriprise »

Ameriprise announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

AMP

Ameriprise

$131.86

3.42 (2.66%)

17:01
04/24/17
04/24
17:01
04/24/17
17:01
Hot Stocks
Breaking Hot Stocks news story on Ameriprise »

Ameriprise raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

AKRX

Akorn

$32.72

-0.19 (-0.58%)

, FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

17:00
04/24/17
04/24
17:00
04/24/17
17:00
Hot Stocks
Akorn backs FY17 adjusted EPS view $1.53-$1.72, consensus $1.63 »

Backs FY17 revenue view…

AKRX

Akorn

$32.72

-0.19 (-0.58%)

FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMP

Ameriprise

$131.86

3.42 (2.66%)

17:00
04/24/17
04/24
17:00
04/24/17
17:00
Earnings
Ameriprise reports Q1 operating EPS $2.70, consensus $2.52 »

Reports Q1 revenue $2.9B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

SMMF

Summit Financial Group

$23.00

0.28 (1.23%)

17:00
04/24/17
04/24
17:00
04/24/17
17:00
Hot Stocks
Breaking Hot Stocks news story on Summit Financial Group »

Summit Financial Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

, AKRX

Akorn

$32.72

-0.19 (-0.58%)

16:59
04/24/17
04/24
16:59
04/24/17
16:59
Hot Stocks
Fresenius to acquire Akorn for $34 per share »

Fresenius Kabi (FSNUY)…

FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

AKRX

Akorn

$32.72

-0.19 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

, AKRX

Akorn

$32.72

-0.19 (-0.58%)

16:58
04/24/17
04/24
16:58
04/24/17
16:58
Hot Stocks
Breaking Hot Stocks news story on Fresenius SE, Akorn »

Fresenius to acquire…

FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

AKRX

Akorn

$32.72

-0.19 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

, AKRX

Akorn

$32.72

-0.19 (-0.58%)

16:58
04/24/17
04/24
16:58
04/24/17
16:58
Periodicals
Breaking Periodicals news story on Fresenius SE, Akorn »

Fresenius SE to acquire…

FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

AKRX

Akorn

$32.72

-0.19 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$53.65

0.65 (1.23%)

16:56
04/24/17
04/24
16:56
04/24/17
16:56
Hot Stocks
Wells Fargo: 'Pleased' with Fed, FDIC findings, committed to 'sound resolution' »

Wells Fargo issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 11

    May

  • 31

    May

  • 13

    Jul

  • 12

    Oct

  • 15

    Jan

OMED

OncoMed

$3.77

0.04 (1.07%)

16:48
04/24/17
04/24
16:48
04/24/17
16:48
Hot Stocks
OncoMed announces workforce reduction »

OncoMed Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

ESRX

Express Scripts

$67.25

0.79 (1.19%)

, ANTM

Anthem

$168.41

0.61 (0.36%)

16:46
04/24/17
04/24
16:46
04/24/17
16:46
Hot Stocks
Express Scripts down 12% after contract with Anthem unlikely to be renewed »

In after hours trading,…

ESRX

Express Scripts

$67.25

0.79 (1.19%)

ANTM

Anthem

$168.41

0.61 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 18

    May

  • 06

    Jun

OI

Owens-Illinois

$21.34

0.83 (4.05%)

16:46
04/24/17
04/24
16:46
04/24/17
16:46
Earnings
Owens-Illinois sees FY17 EPS $2.40-$2.50, consensus $2.43 »

The Company continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

ESRX

Express Scripts

$67.25

0.79 (1.19%)

16:45
04/24/17
04/24
16:45
04/24/17
16:45
Hot Stocks
Breaking Hot Stocks news story on Express Scripts »

Express Scripts trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 06

    Jun

OI

Owens-Illinois

$21.34

0.83 (4.05%)

16:44
04/24/17
04/24
16:44
04/24/17
16:44
Earnings
Owens-Illinois reports Q1 EPS 58c, consensus 53c »

Reports Q1 revenue $1.6B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

WFC

Wells Fargo

$53.65

0.65 (1.23%)

16:44
04/24/17
04/24
16:44
04/24/17
16:44
Hot Stocks
Federal Reserve, FDIC approve revised Wells Fargo living will »

The Federal Deposit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 11

    May

  • 31

    May

  • 13

    Jul

  • 12

    Oct

  • 15

    Jan

ESRX

Express Scripts

$67.25

0.79 (1.19%)

, ANTM

Anthem

$168.41

0.61 (0.36%)

16:43
04/24/17
04/24
16:43
04/24/17
16:43
Hot Stocks
Express Scripts CEO: 'Perplexed' by potential loss of Anthem contract »

Says Anthem deal is…

ESRX

Express Scripts

$67.25

0.79 (1.19%)

ANTM

Anthem

$168.41

0.61 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 18

    May

  • 06

    Jun

SMMF

Summit Financial Group

$23.00

0.28 (1.23%)

16:41
04/24/17
04/24
16:41
04/24/17
16:41
Hot Stocks
Summit Financial Group announces resolution of litigation »

Summit Financial Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$80.05

0.77 (0.97%)

, ESRX

Express Scripts

$67.25

0.79 (1.19%)

16:39
04/24/17
04/24
16:39
04/24/17
16:39
Hot Stocks
Breaking Hot Stocks news story on CVS Health, Express Scripts, Anthem »

CVS up 2% after Express…

CVS

CVS Health

$80.05

0.77 (0.97%)

ESRX

Express Scripts

$67.25

0.79 (1.19%)

ANTM

Anthem

$168.41

0.61 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 02

    May

  • 10

    May

  • 18

    May

  • 06

    Jun

NVS

Novartis

$74.61

1.21 (1.65%)

16:39
04/24/17
04/24
16:39
04/24/17
16:39
Hot Stocks
Novartis expands pact with Amgen to commercialize AMG 334 for migraine »

Novartis (NVS) announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 06

    Jun

  • 26

    Jun

HMN

Horace Mann

$39.25

0.15 (0.38%)

16:39
04/24/17
04/24
16:39
04/24/17
16:39
Earnings
Horace Mann reports Q1 EPS 37c with items, may not compare to consensus 55c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

WNC

Wabash

$20.36

0.64 (3.25%)

16:36
04/24/17
04/24
16:36
04/24/17
16:36
Earnings
Breaking Earnings news story on Wabash »

Wabash sees FY17 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 23

    May

  • 24

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.